Friday, October 25th, 2024

Optimax Holdings: Eyeing Steady Growth with Strong Market Position

Date of Report: October 25, 2024
Broker: CGS International


Overview

Optimax Holdings Berhad is a Malaysian healthcare company specializing in providing eye care services. It operates a network of eye specialist centers across Malaysia, offering a range of services, including cataract surgeries, LASIK, and general eye care. Optimax has established itself as a leading player in the eye care industry, catering to a growing demand for vision correction and eye health services.

Stock Performance

Optimax Holdings is currently listed as a “Buy” in CGS International’s actively managed portfolio. The stock was last traded at RM0.665, reflecting a slight decline from its entry price of RM0.695. Despite the dip, the company remains a part of the portfolio due to its solid fundamentals and market position.

Technical Indicators

  • Entry Price: RM0.695
  • Current Price: RM0.665
  • Stop Loss: RM0.630
  • Target Prices: RM0.77, RM0.795
  • Position: BUY
  • Profit/Loss: -4.3%

Recent Performance Analysis

Optimax’s stock has seen a decline of 4.3% from its entry price, currently trading at RM0.665. While the stock has faced some short-term challenges, the company continues to focus on expanding its service offerings and reaching more customers across Malaysia. Its strong market presence and consistent service delivery are key factors driving its long-term potential.

Investment Strategy

CGS International advises maintaining a buy position for Optimax Holdings, with target prices set at RM0.77 and RM0.795. The recommended stop-loss is at RM0.630, which acts as a risk management measure. Optimax’s ongoing efforts to expand its network of eye care centers and introduce new treatments are expected to support future growth.

Analyst Commentary

CGS International remains optimistic about Optimax Holdings’ long-term growth prospects, emphasizing the company’s strategic initiatives to enhance its service offerings and geographic reach. Although there has been a minor dip in the stock price, the overall market dynamics and Optimax’s leadership in the eye care sector suggest the potential for recovery and further gains. Investors seeking exposure to the healthcare sector, particularly eye care services, may find Optimax Holdings to be a solid addition to their portfolio.


Source: CGS International Trendspotter, October 25, 2024.

PTT Exploration & Production (PTTEP): Navigating Cost Pressures Amidst Profit Decline

Broker: UOB Kay HianDate of Report: October 7, 2024 PTT Exploration & Production (PTTEP): Navigating Cost Pressures Amidst Profit Decline PTT Exploration & Production (PTTEP), Thailand’s leading oil and gas exploration and production company,...

Talga Group Ltd Secures Key Mining Licence, Paving Way for EU Strategic Graphite Project

Date of Report: 21 October 2024Broker: Petra Capital Pty Ltd Mining Licence Granted for Vittangi Graphite Project Talga Group Ltd (TLG) has secured the exploitation concession (mining licence) for the Nunasvaara South graphite mine,...

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024Broker: CGS-CIMB Securities Malaysia Sdn. Bhd. Company Overview Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and...